S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
OTCMKTS:DOCMF

Dr. Martens Stock Forecast, Price & News

$4.95
0.00 (0.00 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.95
$4.95
50-Day Range
$4.95
$6.13
52-Week Range
$4.93
$7.25
VolumeN/A
Average Volume4,204 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DOCMF News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.


Dr. Martens logo

About Dr. Martens

Dr. Martens Limited engages in the manufacture and sale of footwear in the United Kingdom and internationally. Its product segments include originals, fusion, kids and casual, and a complementary range of accessories. The company offers its products under Dr. Martens brand name. It operates Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens Limited was founded in 1960 and is based in London, the United Kingdom.

Headlines

Dr. Martens plc (OTCMKTS:DOCMF) Short Interest Update
October 4, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
N/A
Current Symbol
OTCMKTS:DOCMF
CIK
N/A
Phone
N/A
Employees
1,897
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Dr. Martens (OTCMKTS:DOCMF) Frequently Asked Questions

Is Dr. Martens a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Dr. Martens stock.
View analyst ratings for Dr. Martens
or view top-rated stocks.

What stocks does MarketBeat like better than Dr. Martens?

Wall Street analysts have given Dr. Martens a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Dr. Martens wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Dr. Martens?

Dr. Martens saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 17,000 shares, an increase of 49.1% from the August 31st total of 11,400 shares. Based on an average daily trading volume, of 6,500 shares, the days-to-cover ratio is currently 2.6 days.
View Dr. Martens' Short Interest
.

Who are Dr. Martens' key executives?

Dr. Martens' management team includes the following people:
  • Mr. Kenneth Wilson, CEO & Director (Age 54)
  • Mr. Jon W. Mortimore, CFO & Director
  • Mr. Geert Peeters, Chief Operating Officer (Age 55)
  • Mr. Ronald Garricks, Chief Information Officer
  • Ms. Emily Reichwald, Gen. Counsel & Company Sec.
  • Mr. Darren Campbell, Chief Product & Marketing Officer
  • Ms. Helen Verwoert, Chief HR Officer
  • Mr. Lorenzo Moretti, Pres of EMEA
  • Mr. Leslie Lane, Pres of Americas Region (Age 53)
  • Mr. Sean O'Neill, Chief Digital Officer

Who are some of Dr. Martens' key competitors?

What is Dr. Martens' stock symbol?

Dr. Martens trades on the OTCMKTS under the ticker symbol "DOCMF."

How do I buy shares of Dr. Martens?

Shares of DOCMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dr. Martens' stock price today?

One share of DOCMF stock can currently be purchased for approximately $4.95.

How many employees does Dr. Martens have?

Dr. Martens employs 1,897 workers across the globe.

What is Dr. Martens' official website?

The official website for Dr. Martens is www.drmartensplc.com.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.